Cutaneous and Systemic Reactions to Metal Implants
| Status: | Recruiting |
|---|---|
| Conditions: | Dermatology |
| Therapuetic Areas: | Dermatology / Plastic Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 2/8/2019 |
| Start Date: | August 2014 |
| End Date: | August 2020 |
| Contact: | Marcella Aquino, MD |
| Email: | marcella.aquino@nyulangone.org |
| Phone: | 516-663-2097 |
Cutaneous and Systemic Reactions to Metal Implants: Utility of Patch Testing Prior and Post Placement of Metal Orthopedic Implants
The purpose of this study is to evaluate if metal patch testing in metal allergic patients is
useful for predicting the development of allergic skin disease or systemic symptoms in
patients who recieve a metal orthopedic implant.
useful for predicting the development of allergic skin disease or systemic symptoms in
patients who recieve a metal orthopedic implant.
This prospective cohort study will enroll patients with a history of metal allergy who
require implantation of a metal orthopedic device. Patients will be followed for one year
after surgery to determine if any symptoms including rash, itch, joint pain, joint swelling,
and/or joint failure develop post implantation.
Patients will be recruited from two sites: (1) Divisions of Orthopedics and Allergy &
Immunology, Winthrop University Hospital, and (2) Division of Immunology, and Allergy
Section, University of Cincinnati Medical Center.
require implantation of a metal orthopedic device. Patients will be followed for one year
after surgery to determine if any symptoms including rash, itch, joint pain, joint swelling,
and/or joint failure develop post implantation.
Patients will be recruited from two sites: (1) Divisions of Orthopedics and Allergy &
Immunology, Winthrop University Hospital, and (2) Division of Immunology, and Allergy
Section, University of Cincinnati Medical Center.
Inclusion Criteria
1. Age ≥18 years with a history of metal allergy who require joint repair (hip, knee
and/or shoulder)
2. Able to undergo patch testing
Exclusion Criteria
1. Patients on oral immunosuppressant medications within 4 weeks of patch testing or
topical corticosteroids to the back within 1 week of patch testing
2. Patients who are pregnant or breastfeeding
We found this trial at
2
sites
Click here to add this to my saved trials
Winthrop University Hospital Founded in 1896 by a group of local physicians and concerned citizens,...
Click here to add this to my saved trials